Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs and symptoms of blepharitis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Azithromycin; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• diagnosis of moderate to severe chronic posterior blepharitis

• If female of childbearing potential, are non-pregnant and non-lactating

Exclusion Criteria:

• had ocular surface surgery (LASIK, refractive, pterygium) within the past year

• unwilling to discontinue use of contact lenses during the study

• have glaucoma

• unable or unwilling to withhold the use of eyelid scrubs during the study

• have a serious systemic disease or uncontrolled medical condition that in the judgment of the investigator could confound study assessments or limit compliance

• currently using any preserved topical ocular medications (with the exception of unpreserved tear substitutes) at the time of entry into the study or during study participation